harmaline has been researched along with Dystonic Disorders in 1 studies
Harmaline: A beta-carboline alkaloid isolated from seeds of PEGANUM.
harmaline : A harmala alkaloid in which the harman skeleton is methoxy-substituted at C-7 and has been reduced across the 3,4 bond.
Dystonic Disorders: Acquired and inherited conditions that feature DYSTONIA as a primary manifestation of disease. These disorders are generally divided into generalized dystonias (e.g., dystonia musculorum deformans) and focal dystonias (e.g., writer's cramp). They are also classified by patterns of inheritance and by age of onset.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LeDoux, MS | 1 |
| Lorden, JF | 1 |
1 other study available for harmaline and Dystonic Disorders
| Article | Year |
|---|---|
Abnormal spontaneous and harmaline-stimulated Purkinje cell activity in the awake genetically dystonic rat.
Topics: Action Potentials; Animals; Animals, Newborn; Disease Models, Animal; Dystonic Disorders; Harmaline; | 2002 |